
15.17 Delayed Data As of Mar 23 | ![]() Today’s Change | 11.41 Today|||52-Week Range 18.45 | +17.96% Year-to-Date |
Regeneron (REGN) Gets Label Extension for Cholesterol Drug Mar 22 / Zacks.com - Paid Partner Content | Regeneron (REGN) Gains 9.3% in a Year: Will the Uptrend Last? Mar 17 / Zacks.com - Paid Partner Content |
Previous close | 15.39 |
Today’s open | 15.33 |
Day’s range | 15.04 - 15.34 |
Volume | 2,129,590 |
Average volume (3 months) | 859,332 |
Market cap | $58.8B |
Earnings growth (last year) | +268.98% |
Earnings growth (this year) | -8.14% |
Earnings growth (next 5 years) | +1.35% |
Revenue growth (last year) | +2.35% |
P/E ratio | -- |
Price/Sales | 0.95 |
Price/Book | 1.42 |
No competitors data available. |
Next reporting date | May 11, 2023 |
EPS forecast (this quarter) | $0.76 |
Annual revenue (last year) | $53.3B |
Annual profit (last year) | $4.4B |
Net profit margin | 8.18% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Leverkusen, Nordrhein-westfalen |